Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyager Therapeutics Inc VYGR

Healthcare Biotechnology
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel... see more

Recent & Breaking News (NDAQ:VYGR)

Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinson’s Disease

GlobeNewswire June 21, 2018

Voyager Therapeutics Announces Management Change

GlobeNewswire May 29, 2018

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

GlobeNewswire May 18, 2018

Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

GlobeNewswire May 17, 2018

MRI Interventions Announces Strategic Agreement with Voyager Therapeutics for Neurosurgical Device Service, Supply and Development

GlobeNewswire May 15, 2018

Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights

GlobeNewswire May 10, 2018

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting

GlobeNewswire April 30, 2018

Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 14, 2018

Voyager Therapeutics, Inc. to Host Earnings Call

Accesswire March 14, 2018

Mid-Day Market Update: Dow Turns Negative; United Community Bancorp Shares Spike Higher

Benzinga.com  March 12, 2018

Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease

GlobeNewswire March 9, 2018

Recent Analysis Shows Mobile Mini, Corindus Vascular Robotics, Payment Data, STAAR Surgical, Voyager Therapeutics, and Sunshine Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire March 1, 2018

Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call

GlobeNewswire February 27, 2018

Voyager Therapeutics to Present at Cowen Health Care Conference

GlobeNewswire February 26, 2018

Mid-Day Market Update: Fogo De Chao Gains On Acquisition News; Ubiquiti Networks Shares Slide

Benzinga.com  February 20, 2018

Mid-Morning Market Update: Markets Mostly Lower; Walmart Profit Misses Expectations

Benzinga.com  February 20, 2018

AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer's Disease and Other Tau-Related Neurodegenerative Diseases

PR Newswire February 20, 2018

Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases

GlobeNewswire February 20, 2018

Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference

GlobeNewswire February 7, 2018

Voyager Therapeutics Announces CEO Succession Plan for 2018

GlobeNewswire January 31, 2018